Posted On: 06/09/2014 7:44:17 AM
Post# of 63824
$BDSI a triple at breakout. Pr. $10.00
[url=] Website [/url]
After hours Pr 6/6/14
BioDelivery Sciences Receives FDA Approval for BUNAVAILâ„¢
(buprenorphine and naloxone) Buccal Film for the Maintenance
Treatment of Opioid Dependence
First and Only FDA-Approved Buccal Film Formulation of Buprenorphine
and Naloxone to Compete in the $1.7 Billion and Growing U.S. Opioid
Dependence Market
Late Third Quarter 2014 Launch Anticipated, Utilizing Dedicated Sales Force
Launch Plans to Be Discussed in Late Summer Investor Briefing
news release
Consensus
10-Q 3/31/14
O/S shares 48,458,361
recent trades
Stockwatch
% Buy Opinion (composite)
[url=] Website [/url]
After hours Pr 6/6/14
BioDelivery Sciences Receives FDA Approval for BUNAVAILâ„¢
(buprenorphine and naloxone) Buccal Film for the Maintenance
Treatment of Opioid Dependence
First and Only FDA-Approved Buccal Film Formulation of Buprenorphine
and Naloxone to Compete in the $1.7 Billion and Growing U.S. Opioid
Dependence Market
Late Third Quarter 2014 Launch Anticipated, Utilizing Dedicated Sales Force
Launch Plans to Be Discussed in Late Summer Investor Briefing
news release
Consensus
10-Q 3/31/14
O/S shares 48,458,361
recent trades
Stockwatch
% Buy Opinion (composite)
(0)
(0)
